Kalaris Therapeutics, Inc.

Holding change · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.

Event type

insider.holding_change

Occurred

2026-07-20

Reported

2026-07-20

Disclosure lag

0 days

Context

links are based on the recorded entity type

Field	Recorded value
Entity	Kalaris Therapeutics, Inc.
Source	SEC EDGAR ↗
Source identifier	0001193125-26-309047
Event ID	#974

Recorded payload

JSON payload as stored after parsing

{
  "accession": "0001193125-26-309047",
  "acquired_disposed": "A",
  "code": "A",
  "direct_or_indirect": "D",
  "form": "4",
  "is_derivative": true,
  "issuer_name": "Kalaris Therapeutics, Inc.",
  "label": "Grant or award",
  "person_name": "Bayko Liisa Ann",
  "price": 0,
  "role": "Chief Financial Officer",
  "security": "Stock Option (Right to Buy)",
  "shares": 220000,
  "shares_owned_after": 220000,
  "source_path": "edgar/data/2145720/0001193125-26-309047.txt",
  "ticker": "KLRS",
  "value": null
}

Source: Open recorded SEC filing

Source: SEC EDGAR · as of 2026-07-20T00:00:00Z